Edit
Pii (Pharmaceutics International, Inc.).
http://www.pharm-int.com/Last activity: 06.02.2025
Active
YOUR PARTNER IN ENHANCING LIVES
We Have the Scientific Know-How™
Pharmaceutics International, Inc. (Pii) is a science-driven contract development and manufacturing organization (CDMO) with a single campus in Hunt Valley, MD USA, offering unparalleled scientific insight and depth of product knowledge while supplying high-quality dosage forms that enhance the lives of patients worldwide. Founded in 1994, Pii has grown from 12 employees to over 280 scientists and support staff and over 360,000 square feet of space in the U.S. Pii’s cGMP facilities are state-of-the-art and contain over 70 manufacturing rooms as well as containment suites for handling high potency compounds and hormones, dedicated manufacturing suites for oral products (e.g. soft gels) and injectables (e.g. vials and syringes), a formulation development center and state-of-the-art analytical laboratories.
Your CDMO Partner with Customizable Services
Pii provides customized and flexible solutions, across a wide range of dosage forms and has proven experience with a broad range of drugs and biologics. For twenty-five years, Pii has been supporting its pharmaceutical partners (from virtual to multinational) with extensive technical and regulatory capabilities, Pharmaceutics Know-How™ and the highest level of customer service. With more than 400 development programs completed, Pii’s scientific team has extensive experience working with drugs and biologics representing an ever-widening range of physicochemical characteristics (and challenges). Our specialized capabilities, multi-product facilities and knowledge base allow us to work with potent compounds and hormones, develop complex parenteral and oral dosage forms, and support varied manufacturing processes.
We Have the Scientific Know-How™
Pharmaceutics International, Inc. (Pii) is a science-driven contract development and manufacturing organization (CDMO) with a single campus in Hunt Valley, MD USA, offering unparalleled scientific insight and depth of product knowledge while supplying high-quality dosage forms that enhance the lives of patients worldwide. Founded in 1994, Pii has grown from 12 employees to over 280 scientists and support staff and over 360,000 square feet of space in the U.S. Pii’s cGMP facilities are state-of-the-art and contain over 70 manufacturing rooms as well as containment suites for handling high potency compounds and hormones, dedicated manufacturing suites for oral products (e.g. soft gels) and injectables (e.g. vials and syringes), a formulation development center and state-of-the-art analytical laboratories.
Your CDMO Partner with Customizable Services
Pii provides customized and flexible solutions, across a wide range of dosage forms and has proven experience with a broad range of drugs and biologics. For twenty-five years, Pii has been supporting its pharmaceutical partners (from virtual to multinational) with extensive technical and regulatory capabilities, Pharmaceutics Know-How™ and the highest level of customer service. With more than 400 development programs completed, Pii’s scientific team has extensive experience working with drugs and biologics representing an ever-widening range of physicochemical characteristics (and challenges). Our specialized capabilities, multi-product facilities and knowledge base allow us to work with potent compounds and hormones, develop complex parenteral and oral dosage forms, and support varied manufacturing processes.
Location: United States, Maryland, Cockeysville
Employees: 201-500
Total raised: $93M
Founded date: 1994
Investors 2
| Date | Name | Website |
| - | Hildred | hildred.co... |
| - | Signet Hea... | signetheal... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.09.2016 | - | $93M | - |
Mentions in press and media 9
| Date | Title | Description |
| 06.02.2025 | Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc. | NEW YORK--(BUSINESS WIRE)--A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics International, ... |
| 15.01.2019 | Pharmaceutical Industry Veteran Dr. Kurt R. Nielsen to lead Pharmaceutics International, Inc. | HUNT VALLEY, Md., Jan. 15, 2019 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the appointment of Kurt R. ... |
| 11.06.2018 | Pii Announces Positive Inspection News from FDA and MHRA | Posted on Jun 11, 2018, 09:00 ET HUNT VALLEY, Md., June 11, 2018 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, Maryland, received notification on Jun... |
| 06.09.2016 | Pharmaceutics International, Inc. (Pii) Receives $93 Million In Growth Capital | HUNT VALLEY, MARYLAND, September 6, 2016 /PRNewswire/ -- Pharmaceutics International, Inc. ("Pii"), a contract development and manufacturing organization ("CDMO") based in Hunt Valley, MD, announced today that it has ent... |
| 06.09.2016 | Pharmaceutics International, Inc. (Pii) Receives $93 Million In Growth Capital | HUNT VALLEY, MARYLAND, September 6, 2016 /PRNewswire/ -- Pharmaceutics International, Inc. ("Pii"), a contract development and manufacturing organization ("CDMO") based in Hunt Valley, MD, announced today that it has ent... |
| 06.09.2016 | Pharmaceutics International Receives $93 Million In Growth Capital | Pharmaceutics International, Inc., a contract development and manufacturing organization based in Hunt Valley, MD, announced today that it has entered into a definitive agreement with a consortium of investors led by Signet Healthcare Partn... |
| - | Pharmaceutics International | “Pii has experience, commitment, & energy for your aseptic fill-finish, oral solid dose, semi-solid, tech transfer, and more.” |
| - | Pharmaceutics International | “Pii is a CDMO with 30 years of experience offering concept to clinic to commercialization for your drug candidate. We have the ability to handle highly potent compounds, hormones, and cytotoxics for oral and injectable drug products.” |
| - | Pharmaceutics International | - |